OptimizeRx Continues Coronavirus Conversation Series with Leaders of NextGen and Illumina
2020年3月25日 - 11:39PM
OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital
health solutions for life science companies and payers, will
continue its webinar series on navigating the coronavirus
(COVID-19) this week with leaders from NextGen and Illumina.
The ongoing conversations are part of OptimizeRx’s initiative to
facilitate industry collaboration to help stop the spread of the
virus. More than 400 members of the healthcare community have
participated in the webinars which began last week.
William Febbo, CEO of OptimizeRx, will lead the panel. He will
be joined by Rusty Frantz, president and CEO of NextGen, and Phil
Febbo, chief medical officer and SVP of Illumina. The panel will be
moderated by Rebecca Love, VP of customer strategy and engagement
for OptimizeRx.
Topic: Learning Together: Frontline HCP Communication
During COVID-19This webinar is designed to be a resource
for HCPs and healthcare executives as we all learn together to
navigate the COVID-19 pandemic. Approaching the topic from a
variety of angles (providers, digital health messaging, and EHR
communications), the panel will provide a valuable opportunity for
participants to learn and engage with industry leaders in this
discussion about designing solutions to combat the coronavirus.
Date: Thursday, March 26Time:
1:00 p.m. ET
The webinar is free and open to anyone in the industry and will
provide an opportunity to communicate directly with the panelists.
OptimizeRx continues to host a series of crucial conversations
connecting various healthcare stakeholders to drive innovation,
collaboration and education.
Register today at www.optimizerx.com/webinars.
For more information about OptimizeRx’s webinar sessions,
contact media relations at (754) 245-7070 or
malejandra@optimizerx.com.
About OptimizeRxOptimizeRx® (NASDAQ: OPRX), a
digital health company, connects pharmaceutical companies to
patients and providers, offering greater affordability, adherence
and brand awareness at the point-of-care. As the nation’s largest
digital platform connecting life sciences to the point-of-care,
OptimizeRx provides a direct channel for pharma companies, payers,
medtech, and medical associations to communicate with healthcare
providers right within their workflow and also directly to
patients.
The cloud-based solution supports patient adherence to
medications and better healthcare outcomes with real-time access to
financial assistance, prior authorization, education and critical
clinical information. OptimizeRx provides more than half of the
ambulatory patient market with access to these benefits through
leading EHR platforms like Allscripts, Amazing Charts and Quest,
and directly via its mobile communications platform and digital
therapeutics SaaS platform.
For more information, follow the company on Twitter, LinkedIn or
visit www.OptimizeRx.com.
Important Cautions Regarding Forward Looking
StatementsThis press release contains forward-looking
statements within the definition of Section 27A of the Securities
Act of 1933, as amended, and such as in section 21E of the
Securities Act of 1934, as amended. These forward-looking
statements should not be used to make an investment decision. The
words 'estimate,' 'possible' and 'seeking' and similar expressions
identify forward-looking statements, which speak only as to the
date the statement was made. The company undertakes no obligation
to publicly update or revise any forward-looking statements,
whether because of new information, future events, or otherwise.
Forward-looking statements are inherently subject to risks and
uncertainties, some of which cannot be predicted, or quantified.
Future events and actual results could differ materially from those
set forth in, contemplated by, or underlying the forward-looking
statements. The risks and uncertainties to which forward-looking
statements are subject include, but are not limited to, the effect
of government regulation, competition, and other material
risks.
OptimizeRx Contact Doug Baker, CFOTel (248)
651-6568 x807 dbaker@optimizerx.com
Media Relations Contact Maira Alejandra, Media
Relations ManagerTel (754) 245-7070 malejandra@optimizerx.com
Investor Relations Contact Ron Both, CMATel
(949) 432-7557 oprx@cma.team
OptimizeRx (NASDAQ:OPRX)
過去 株価チャート
から 6 2024 まで 7 2024
OptimizeRx (NASDAQ:OPRX)
過去 株価チャート
から 7 2023 まで 7 2024